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Abstract
Purpose The purpose of this paper is to study the presentation
and analyse the results of multimodality treatment of brain
arterio-venous malformations (AVMs) in children at our cen-
tre and review age at first AVM rupture in the literature.
Methods Of 52 patients aged <18 years, 47 with brain AVMs
(27 males and 20 females) aged 4–17 years (mean 12.2) were
retrospectively reviewed. PubMed search revealed five addi-
tional studies including 267 patients where the prevalence of
age-related AVMs rupture was analysed.
Results In our study, 37 patients had bled, 9 were symptomatic
without haemorrhage and 1 was incidental. Spetzler-Martin
score distribution was 5 cases grade I, 18 grade II, 21 grade III
and 3 grade IV. Appropriate imaging was performed, either CT/
MRI angiogram only (in emergency cases) or catheter angio-
gram, prior to definitive treatment. There were 40 supratentorial
and 7 infratentorial AVMs. Twenty-nine patients had microsur-
gery alone and 9 patients were treated by radiosurgery only.
Three patients were embolised, all followed by radiosurgery,
with one requiring surgery too, while 4 patients had combined
surgery and radiosurgery. One patient is awaiting radiosurgery
while another was not treated. Good outcomes, classified as
modified Rankin score (mRS) 0–2 improved significantly after
intervention to 89.4% from 38.3% pre-treatment (p value
<0.0001). Angiography confirmed 96.6% obliteration after first
planned operation. Repeat cerebral angiogram around age 18
was negative in all previously cured patients. Reviewing the
literature, 82.0% (95% CI = [77–87]; N = 267) of children
diagnosed with brain AVMs (mean age 11.4 ± 0.4) presented
with a bleed in the last 22 years. Males significantly
outnumbered females (136 vs 84) (p < 0.001). Ninety-five pa-
tients underwent surgical intervention alone when compared to
other treatment modalities (p < 0.001).
Conclusions Microsurgical excision of surgically accessible
intracranial AVMs remains the primary treatment option with
very good outcomes. A significant number of patients’ AVMs
ruptured around puberty; therefore, understanding the patho-
physiology of AVM instability at this age may aid future
therapy.
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Introduction
Impaired embryological differentiation of primordial vascular
channels is believed to have a significant congenital role in
developing brain arterio-venous malformation (AVM) anom-
alies [1, 2]. About 12–18% of patients who presented with
brain AVMs are among children [3]. Brain AVMs result in
35%–55% of haemorrhagic strokes in children, with an inci-
dence of 1.4 per 100,000 person-years and significant mortal-
ities and morbidities [4, 5]. In one series, mortality reached
25%when averaged over 40 years, with an improvement from
39 to 16% over this time, coinciding with technological ad-
vances [6]. The annual bleeding risk of ruptured AVMs in
children was reported as 2.71% and increased when associated
with aneurysms and deep venous drainage [7]. In the
Blauwblomme et al. study, AVMs ruptured at a mean age of
9.7 years (range 7.0–12.7). Furthermore, assuming that AVMs
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are congenital lesions, they estimated that the annual bleeding
risk is 6.3% with significant associations with female sex
(49.4% females vs 37.5% males) and annual re-haemorrhage
rate of 14.8% [8]. The number of patients that have been
diagnosed with AVMs in the neonatal period or infancy is very
small [9, 10] and none to date has been diagnosed in utero in
spite of the advances in radiological diagnostic techniques,
including the now routine use of good quality ultrasound im-
aging [11]. Another recent study reported a mean age of AVM
rupture of 11.3 years [12]. Thus, the vast majority of children
with ruptured AVMs presented around or after the onset of
puberty. This observation raises questions about the patho-
physiology of AVMs and whether pubertal changes induce
instability.
AVM treatment is essentially aiming at achieving angio-
graphic cure (abolition of arterio-venous shunting) with no
or minimal risk. This can be achieved by either surgical exci-
sion of the AVM nidus, endovascular complete AVM nidus
embolisation, radiosurgical thrombo-obliteration or by a com-
bination of these modalities. Previous studies have shown that
up to 18% of children with AVMs were deemed untreatable
[10, 13]. This may well be down in part to difficulties in
applying multidisciplinary methods when addressing such
complex cases. However, flexibility, expertise and ap-
proaching AVMs with more than one modality of treatment
available improve the outcomes and reduce morbidity and
mortality [7, 12].
In our centre, a multidisciplinary team of neurovascular
neurosurgeons, interventional neuroradiologists and input as
appropriate from our radiosurgery referral centre were utilised
to plan treatment for children with AVMs over the last
22 years. The most suitable individual treatment strategy
was developed, consisting of surgical AVM resection,
endovascular embolisation, radiosurgery or a combined treat-
ment policy.
The purpose of this study is to present our experience since
1994 using this multimodality treatment approach in the man-
agement of ruptured and unruptured paediatric brain AVMs
and review age-related AVMs rupture risk in the literature.
Methods
A prospectively maintained database (OCS-senior author) of
vascular malformation patients treated at Wessex
Neurological Centre was searched to identify all patients
whose first AVM presentation/treatment occurred before
18 years of age between 1994 and 2016.We initially identified
52 patients. Of these, 47 individuals (27 males and 20 fe-
males) were confirmed to have brain AVMs, so were included
in the retrospective analysis. The five excluded patients were a
single AVM patient—seen after the 18th birthday, one with a
traumatic carotico-cavernous fistula, two patients with scalp
fistulae (so-called Bcirsoid aneurysms^), and the last one had a
simple sinus pericranii. AVMs were primarily diagnosed and
followed up using catheter cerebral digital subtraction angiog-
raphy (DSA). Occasionally, in cases of acutely ruptured
AVMs with significant mass effect, computed tomographic
angiography (CTA) or magnetic resonance angiography
(MRA) was considered adequate to delineate the AVM nidus
and angio-architecture. All the resected AVMs were also ver-
ified by histopathological examination. All cases have been
discussed by the neurovascular multidisciplinary team, which
includes other vascular neurosurgeons and interventional neu-
roradiologists. AVMs were classified according to the
Spetzler-Martin grading system, and location was noted.
Retrospective outcome analysis using a dichotomised
Modified Rankin Scale score (mRS 0–2 good outcome, 3–6
poor outcome) was performed after stabilising the patient and/
or seizure control before surgery, and at follow-up. Any intra-
operative or postoperative complications were analysed. A
PubMed search was conducted for ruptured brain AVMs in
children. We scanned titles, abstracts and whole papers of
relevant information. Five studies included data about age/
sex when AVMs ruptured, so were eligible for inclusion in
our review. Two hundred and sixty-seven patients were in-
cluded (five literature studies and our series) of whom 220
patients presented with AVM rupture. Studies lacking the rel-
evant information specific to our review were not included.
The collected data were analysed retrospectively using
Microsoft Office Excel 2013 (Microsoft, USA). Statistical
analysis using Graph Pad Prism (USA) Student’s t test or the
chi-square test was performed as appropriate. Period preva-
lence for ruptured AVMs with 95% confidence intervals (CI)
was calculated using the Clopper-Pearson exact test. P value
<0.05 was considered significant.
Results
Figure 1 illustrates patient demographics. There were 27
males and 20 females with a mean age of 12.2 years (range,
4–17 years). Of these 47 patients, 37 (78.7%) had bled.
Seventy-nine percent (95% CI = [64–89]; N = 47) of children
who were diagnosed with AVMs (mean age 12.1 ± 0.6) pre-
sented with rupture over the last 22 years. Patients who pre-
sented with a bleed had either headache, reduced level of
consciousness or both. Nine (19.2%) patients were symptom-
atic without haemorrhage, of whom five had seizures and four
were only complaining of headaches. In one patient (2.1%), an
AVM was diagnosed incidentally.
On admission to the Wessex Neurological Centre 18 pa-
tients had a Glasgow Coma Score (GCS) of 15, 10 patients
were GCS 13–14, 2 patients had GCS 9–12, and 16 patients
were GCS of ≤8. One patient was initially treated at another
centre; hence, the GCS is not recorded.
574 Childs Nerv Syst (2017) 33:573–581
AVM location In 40 patients, the AVM was supratentorial
(frontal lobe 9, parietal lobe 7, temporal lobe 7, occipital lobe
6, parieto-occipital 3, temporo-parietal 2, fronto-temporal 1,
basal ganglia and/or thalamus 3, corpus callosum 2) and
infratentorial in the other 7 (all cerebellar) (Table 1). The
Spetzler-Martin grade (Fig. 2) was as follows: grade 1 in 5
cases, grade 2 in 18, grade 3 in 21, and 3 were grade 4. In 3
patients (6.4%), the AVM was associated with a flow-related
aneurysm.
Patients underwent digital subtraction angiography (DSA)
and MRI with MR angiography (MRA) when possible, were
discussed in the neurovascular meeting as appropriate and the
most suitable modality of treatment was arranged. Twenty-
nine patients had microsurgery alone; while in nine patients,
radiosurgery only was sufficient to obliterate the AVM. One
further recently diagnosed patient is awaiting radiosurgery.
Three patients were embolised, all followed by radiosurgery,
with one requiring microsurgery too. Four patients required a
combined approach with surgery and radiosurgery to achieve
satisfactory results, see Table 2. One patient arrived moribund
with failing circulation despite huge doses of inotropes, in
coma (GCS 3) with unreactive pupils unresponsive to manni-
tol and was not treated.
In 83% (39/47) of the patients described, an angiographic
cure of the AVM was achieved after treatment. One recently
diagnosed patient (2.1%) is awaiting radiosurgery treatment.
Six patients (12.8%) had residual AVM after the planned treat-
ment had been completed. One patient was from the surgical
group, 2 patients were from the radiosurgery group and three
patients were from those who were managed with more than
one planned modality of treatment (but when all had been
completed). Patients who were suitable candidates for radio-
surgery were referred to the Sheffield Radiosurgery Centre,
where they underwent that treatment only. However, we have
followed all up. An experienced interventional neuroradiolo-
gist (JM) at the Wessex Neurological Centre performed
endovascular treatments.
Evacuation of a space-occupying haematoma was neces-
sary in five patients among the 37 with ruptured AVMs
(10.6%). In one patient, the haematoma was acutely evacuatedTable 1 AVM localisation. This table demonstrates the numbers and
location of the AVMs
Location Number of patients (%)








Thalamus/basal ganglia 3 (6.4%)
Corpus callosum 2 (4.3%)
Cerebellum 7 (14.9%)
Fig. 1 All patients’
demographics. Age and sex
distribution at diagnosis
Fig. 2 AVM grading. Patients’AVM classification according to Spetzler
and Martin AVM grading
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with simultaneous surgical resection of the AVM. In the re-
maining four patients, the haematoma was evacuated without
removal of the AVM. Seven patients required insertion of an
external ventricular drain and subsequently two patients re-
quired permanent ventriculo-peritoneal shunts to divert CSF
(Table 2).
Surgery was performed following the standard principles
of microsurgical AVM resection. Image guidance was used
when available and deemed advantageous. AVM localisation
and identification was sometimes difficult, when small or
somewhat diffuse, planning being conducted using a combi-
nation of DSA, CTA and MRI/MRA employing image
guidance.
Clinical outcomes were measured by mRS and compared
initial mRS at first presentation, after stabilising the patient
and/or seizure control, to that either at discharge or at the latest
follow-up clinic visit. The results are displayed in Fig. 3. Good
outcomes, classified as mRS 0–2, improved significantly after
intervention to 89.4% from 38.3% pre-treatment (p value
<0.0001). The breakdown was mRS 0 in 4 patients pre-
surgery and 16 after treatment, mRS 1 in 5 cases pre-
surgery and 14 on follow-up, mRS 2 in 9 patients pre-
operation and in 12 on last clinic visit, mRS 3 in 4 cases
pre-surgery and 3 on follow-up, mRS 4 in 9 patients pre-
surgery but only 1 on follow-up, mRS 5 in 16 patients pre-
surgery and none on last clinic visit, and finally one patient
who was mRS 5 on admission was not treated and
succumbed (mRS 6).
Imaging confirmed obliteration of AVMs in 29 cases from
the surgery only group, while 7 patients who had radiosurgery
only were cured. One patient is awaiting radiosurgery treat-
ment. The rest underwent more than one treatment modality
before achieving cure. We noted that para-trigonal AVMswith
intraventricular haemorrhage were difficult to treat, often ne-
cessitating more than one modality of treatment. Some pa-
tients required more than one operation and/or more than
one session of radiosurgery. Catheter cerebral angiography
around age 18 is performed in all paediatric AVM patients,
once vascular plasticity is assumed to have reduced. It has
proved reassuringly negative in all patients who had been
deemed cured previously. Of the nine patients who initially
had seizures with/without haematoma, seven were seizure-
free at last clinical follow-up. However, one patient developed
seizures a few months after surgery and another one devel-
oped seizures 1 year after radiosurgery.
We observed transient procedure-related morbidity in three
patients who had undergone emergency operations to either
evacuate haematomas or divert CSF to reduce intracranial
pressure. Of these, one patient developed ventriculitis while
another had a CSF infection. Both were treated successfully
with good outcome. A third patient, who developed wound
infection, required antibiotics. Over the longer term, one pa-
tient developed a subdural hygroma and two additional pa-
tients needed permanent ventriculo-peritoneal shunts after
acute hydrocephalus had required EVD insertion.
Discussion
Although the prevalence of childhood AVMs is difficult to
assess, it has been suggested that it is less than 1% at autopsy;
however, this may have changed recently with the frequent
use of modern imaging modalities leading to more incidental
AVMs being diagnosed [14]. The annual risk of AVM haem-
orrhage in children is approximately 2–6% per annum (assum-
ing presence from birth) and is higher in the first year post
rupture [7, 8, 15–18]. However, age-related prevalence of
haemorrhage among children diagnosed with brain AVMs is
not clear in the literature. In spite of the proposed congenital
theory of AVMs formation, the number of neonates and young
children diagnosed/treated for such pathology is very small [1,
7, 8, 17]. Furthermore, recurrence of brain AVMs after
Table 2 Treatment modalities. We show the different treatment options
our patient underwent and their percentages among all
Method Number of patients (%)
Surgery (only) 29 (61.7)
Total excision first definitive procedure 28 (59.6%)
Total excision second definitive procedure 1 (2.1%)
Haematoma evacuation as first procedure 5 (10.6%)
CSF Diversion (temporary) 7 (14.9%)
CSF Diversion (permanent-shunt) 2 (4.3%)
Radiosurgery (only) 10 (21.3)a
Endovascular embolisation and radiosurgery 3 (7%)
Embolisation, radiosurgery and surgery 1 (2.1%)
Surgery and radiosurgery 4 (8.5%)
No treatment 1 (2.1%)b
a One patient is awaiting radiosurgery
bOne patient arrived moribund, unresponsive to mannitol, therefore no
further treatment
Fig. 3 mRS scores. This figure demonstrates good outcome (mRS 0–2)
compared to poor outcome (mRS 3–6) on follow-up after treatment was
completed. We report significant improvement in good outcome
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angiographic cure has been reported in a number of cases
[19–22]. Interestingly, Yeo et al. reported diagnosing de novo
brain AVMs in two children where MRI scans (as a workup
for seizures) were normal years earlier [23]. Altogether, this
may suggest multifactorial pathophysiology of brain AVMs
and/or their instability rather than a purely congenital origin
and an even subsequent annual risk of rupture.
Brain AVMs in the paediatric age group account for 30–
50% of haemorrhagic strokes [3, 24]. A high percentage of
children with AVMs, often more than 60%, present with rup-
ture [7, 8, 15, 17, 25]. In our series, 78.7% presented with
haemorrhage. It has also been reported that children often
present with haemorrhage from AVMs when compared to
their adult counterparts [26]. Indeed, some published series
report haemorrhage rates of 80–85%, resulting in mortality
of up to 25% [6, 13, 25]. Importantly, the natural history of
untreated ruptured brain AVMs in children is not favourable,
with high morbidity and mortality [27]. Over one third of
patients present with or develop seizures due to brain AVMs
and/or haemorrhage [11, 28]; in our study, 19% of patients had
seizures at presentation but few of them remained on antiep-
ileptic medication on last follow-up. However, a further 4.2%
developed seizures months to years after treatment. Overall,
we report 9% long-term seizures in our series. Given the re-
portedly high morbidity and mortality of brain AVMs in chil-
dren, it is therefore crucial to outline a strategy to implement
the optimum treatment modality to achieve permanent oblit-
eration of the AVM nidus with minimal risks. Although the
previously published series of AVMs in children came from
well-known large neurosurgery centres, the number of pa-
tients in each study is small. We report 47 patients of whom
33 had surgery; mostly (29) surgery only.We also demonstrate
a very low mortality rate (2.1%) at our tertiary referral centre
with a catchment population of around 3 million people over a
period of more than 22 years.
In common with others [7, 15], we advocate a multidisci-
plinary approach utilising multimodality treatment options in-
cluding combining different treatment strategies to maximise
the permanent nidus obliteration rate with low treatment mor-
bidity. Our results and recent reports [7, 12, 15] add support to
this concept. As an example, Fig. 4 demonstrates a right tha-
lamic haemorrhage from an aneurysm on the artery of
Percheron, in turn feeding the AVM. The patient presented
with sudden onset headache and collapse with a GCS of 4/
15; she had an emergency EVD followed by DSA and embo-
lisation of the aneurysm and feeder using an ethylene vinyl
alcohol copolymer (Onyx™) followed by radiosurgery with
complete AVM/aneurysm obliteration (Fig. 5) and good re-
covery to mRS of 3. In centres where only a single or a com-
bination of two treatment modalities is available, the number
of patients in whom the treatment risks are deemed to exceed
the calculated risks of natural history, and who therefore re-
main untreated, is comparatively high [13]. The availability of
better neurosurgical/interventional facilities, including radio-
surgery centres in the UK, has encouraged us and others to
utilise more active and appropriate treatment strategies, yield-
ing improved outcomes.
Multidisciplinary review and the use of a balanced
multimodality approach in the management of paediatric brain
AVMs reduce procedure-related morbidity and mortality, and
increase treatment efficacy. In our study, we demonstrate sig-
nificant improvement in outcome (mRS 0–2 in 89.4% after
intervention, from 38.3% after initial resuscitation) (Fig. 3).
Microsurgery, plays a key role in every therapeutic strategy
for the management of both adult and paediatric brain AVMs.
However, surgery should remain one component in the arma-
mentarium for AVM management and there is a risk that sur-
gical approaches outside a balanced multimodality treatment
strategy can result in higher procedural morbidity rates and
poorer neurological outcomes when compared to combined
treatment plans [25]. This applies particularly to high
Spetzler-Martin grade lesions, such as the larger and deep
AVMs [15]. Thirty-three cases underwent surgical interven-
tion in our series, of which 29 patients had surgery alone.
Looking at the ruptured AVMs group in our study, we noted
that 25 patients had surgery only. The decision to recommend
surgery depended onmany factors includingMDT discussion,
Spetzler-Martin grade and the accessibility of the lesion with
minimal risk. We noted that deep AVMs, eloquent and para-
trigonal lesions were often difficult to obliterate surgically,
requiring a multimodality approach.
In our study, emergency evacuation of haematomas was
required in five patients only of the ruptured brain AVMs
treated. Seven patients required EVD placement, of whom
two required permanent V-P shunts (Table 2). The ruptured
AVMs were mostly treated in a delayed fashion after DSA
and MRI/MRA, and discussion at the MDT meeting. The
treatment options included a combination of different treat-
ment modalities taking account of potential procedural com-
plications, including sequential risks of more than one treat-
ment, balanced against the risk of AVM re-bleeding (Figs. 4
and 5). Since protection from AVM re-bleeding is provided
only after angiographic documentation of permanent nidus
and arterio-venous shunt obliteration, haematoma evacuation
without surgical AVM removal as well as subtotal nidus
resection are acceptable only as emergency measures within
a treatment strategy aiming at definitive cure of the malfor-
mation on an elective or semi-elective basis. All cases un-
dergo DSA after 3 months, to assess the efficacy of surgery.
We describe 39 (83%) patients with negative cerebral cath-
eter angiogram after initial treatment. Six patients had resid-
ual AVM at follow-up (1 from the surgical group only, 2
from the radiosurgery group and 3 from the combined treat-
ment group) (Table1). Initial treatment was planned as sur-
gery alone, radiosurgery only, embolisation alone or a
planned combined approach. This combined approach was
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needed in 2 cases where patients had surgery then radiosur-
gery. This is considered a high success rate after the initial
treatment. Moreover, repeat DSA at 18 years old for those
who have reached that age has remained negative, and there-
fore these patients have been discharged.
The conventional model is that AVMs are congenital le-
sions that arise from the abnormal development of the
arteriolo-capillary network between the arterial and venous
circulations within an organ [29]. However, the timing, stim-
ulus and early architectural deficiencies in the AVM are not
Fig. 5 DSA images. a Pre-
treatment DSA picture reveals the
aneurysm (arrow) and the AVM
nidus (arrowhead). b Post-
embolisation DSA demonstrates
occlusion of the aneurysm.
Follow-up images demonstrating
the BOnyx^ cast (arrow) in the
flow aneurysm (c) and a DSA re-
veals obliteration of the AVM
(arrowhead) (d)
Fig. 4 Case illustration. a Pre-
treatment CT, which shows a right
thalamic bleed with intraventric-
ular extension and hydrocephalus
after external drainage placement.
b Axial CT angiogram image re-
veals the Percheron artery flow
aneurysm projecting into the third
ventricle (arrow) and AVM nidus
(arrowhead). c A 3D CT angio-
gram picture that delineates the
flow aneurysm (arrow) and the
AVM nidus (arrowhead)
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well understood. It has long been thought that the defects
occur before the embryo is 44-mm in length (this is the stage
of definitive formation of the adult pattern of arterial wall
structure) [29]. To date and in spite of the advances in antena-
tal diagnosis of foetal anomalies, we could identify no reports
of brain parenchymal AVMs diagnosed in utero. This may
suggest that either these lesions have not developed yet or else
they have not reached a size where they have become visible
with the techniques currently available. Literature reports sug-
gest most children diagnosed with AVMs are in their adoles-
cence, with a small number of patients under the age of 8 years,
and hardly any under the age of 1 [1, 3, 10, 12, 14, 15, 17, 25].
In our series, the mean age was 12.2 ± 3.8, matching the age of
adolescence. We had 20 female patients of whom only 7 were
under the age of 10. The other 27 were males, only 4 being
under the age of 10. It may be significant that puberty com-
mences at a younger age in females than males in developed
countries. There will inevitably be some patients who were
treated urgently elsewhere; however, the vast majority will
have been treated and followed up in our unit. The absence
of infants or neonates is noteworthy, an observation common
to other studies. We propose the mechanisms of AVM forma-
tion (and/or enlargement) or perhaps a period of instability
commencing around the age of puberty, provokes the cluster-
ing of bleeds around this age, and warrants further consider-
ation. As we noted in our study, in common with others, most
of these patients present with a bleed during puberty/adoles-
cence, casting some doubt on the mechanism of AVM forma-
tion being purely congenital. In addition, recurrence of brain
AVMs after angiographic cure suggests a possible alternative
mechanism of AVMs formation [20, 22]. In line with this
theory, we have further reviewed the literature and identified,
in addition to our series, five more studies [7, 12, 17, 25, 26]
where age/sex at rupture of AVMs, where patients’
Table 3 Literature review studies. This table shows the six studies included in our review, the total number of patients who are below 18 years old, the
number of patients and mean age at rupture, sex distribution and the modalities of treatment specifically for ruptured AVMs
Series Total number
of patients
Ruptured AVMs (%) Mean age
at rupture
in years
Sex (ruptured only) Treatment modality of ruptured AVMs (%)
M F




Abecassis et al. 2016 22a 14 (64) 12.2 11 3 Surgery alone 3 (21)
Radiosurgery alone 3 (21)
Embolisation alone 0
Combined 8 (58)
Blauwbiomme et al. 2014 106 106(100)b 9.7 62 44 Surgery alone 43 (40.6)
Radiosurgery alone 8 (7.5)
Embolisation alone 12 (11.3)
Combined 43(40.6)












a Patients 18 and above were excluded
b This is a ruptured AVMs series only
c One patient is awaiting radiosurgery
dOne patient did not have any treatment (died)
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demographics were available for analysis. There were 267
patients included in the review (Table 3). Two hundred and
twenty patients presented with rupture of their AVMs. In our
literature review we report that 82% (95% CI = [77–87];
N = 267) of children diagnosed with brain AVMs (mean age
11.4 ± 0.4) presented with rupture over the last 22 years in-
cluded. In spite of a previous report of increased risk of haem-
orrhage associated with female sex [8], our review revealed a
significant difference in gender-related AVM rupture (136
males vs 84 females) (p < 0.001). These findings perhaps
propose that hormonal changes around puberty may be relat-
ed, and suggest that the sex difference may be attributable to
the hormonal differences too. Unfortunately, we did not per-
form any sex hormone measurements in our cases. We further
analysed the available data of modality of treatment for 201
patients (Table 3), which shows that 95 had surgery only, 23
underwent radiosurgery alone, 12 had embolisation alone and
71 had combined approaches. Surgical intervention was sig-
nificantly higher than any other treatment modality with good
outcomes (p < 0.001). Regarding AVM pathophysiology, var-
ious animal models have implicated sex hormones in playing
an important role in angiogenesis through vascular endothelial
growth factor (VEGF) and its receptors [30–32]. Inhibiting
angiogenesis using doxycycline has even been proposed to
have a role in the treatment of AVMs in patients [33].
Interestingly, it has been reported that testosterone remodels
aortic wall in arterio-venous fistulae [34]. These studies may
suggest that enhancement of angiogenesis along with other
factors, currently obscure, may have an important role in gen-
erating instability in AVMs or even provoking AVM forma-
tion. Our review (Table 3) shows that approximately 62% of
ruptured AVMs are among males and whether there is a co-
relation with hormonal changes and/or testosterone levels is
not known. Further research in this field may lead to novel
therapy applicable even to the inoperable cases.
To conclude, although brain AVMs in children are
rare, they represent a serious lifelong risk of haemor-
rhage and neurological deficits. Most children will pres-
ent with an intracranial bleed when compared to the
adult population; a multidisciplinary discussion and ap-
proach should to be standard for each case, considering
the various treatment options available. Endovascular
embolisation is usually utilised as an adjunct, combined
with either surgery, radiosurgery or both to achieve better
cure rates. Microsurgical excision is the treatment of
choice in low-grade, accessible and non-eloquent AVMs
with very good outcomes. Though a congenital aetiology
has been assumed, as most patients present in adoles-
cence, there must be some doubt over either their forma-
tion or alternative explanations for this clustering in age
of haemorrhages. Further investigation of the pathophys-
iology and/or stability of AVMs at various ages may lead
to new treatment strategies.
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